These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 25008452)

  • 1. Circulating tumour cells and the epithelial mesenchymal transition in colorectal cancer.
    Lim SH; Becker TM; Chua W; Ng WL; de Souza P; Spring KJ
    J Clin Pathol; 2014 Oct; 67(10):848-53. PubMed ID: 25008452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer.
    Zhao R; Cai Z; Li S; Cheng Y; Gao H; Liu F; Wu S; Liu S; Dong Y; Zheng L; Zhang W; Wu X; Yao X
    Oncotarget; 2017 Feb; 8(6):9293-9302. PubMed ID: 28030836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
    Yokobori T; Iinuma H; Shimamura T; Imoto S; Sugimachi K; Ishii H; Iwatsuki M; Ota D; Ohkuma M; Iwaya T; Nishida N; Kogo R; Sudo T; Tanaka F; Shibata K; Toh H; Sato T; Barnard GF; Fukagawa T; Yamamoto S; Nakanishi H; Sasaki S; Miyano S; Watanabe T; Kuwano H; Mimori K; Pantel K; Mori M
    Cancer Res; 2013 Apr; 73(7):2059-69. PubMed ID: 23378342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
    Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
    PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
    Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
    Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition.
    Lowes LE; Allan AL
    Adv Clin Chem; 2018; 83():121-181. PubMed ID: 29304900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Circulating tumor cells: a new challenge for laboratory medicine].
    Séronie-Vivien S
    Ann Biol Clin (Paris); 2014; 72(2):153-77. PubMed ID: 24736136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research.
    Grover PK; Cummins AG; Price TJ; Roberts-Thomson IC; Hardingham JE
    Ann Oncol; 2014 Aug; 25(8):1506-16. PubMed ID: 24651410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Looking back, to the future of circulating tumor cells.
    Friedlander TW; Premasekharan G; Paris PL
    Pharmacol Ther; 2014 Jun; 142(3):271-80. PubMed ID: 24362084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rationale for liquid biopsy in colorectal cancer: a focus on circulating tumor cells.
    Gazzaniga P; Raimondi C; Nicolazzo C; Carletti R; di Gioia C; Gradilone A; Cortesi E
    Expert Rev Mol Diagn; 2015; 15(7):925-32. PubMed ID: 25959553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer.
    O'Flaherty JD; Gray S; Richard D; Fennell D; O'Leary JJ; Blackhall FH; O'Byrne KJ
    Lung Cancer; 2012 Apr; 76(1):19-25. PubMed ID: 22209049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Circulating tumor cells: liquid biopsy].
    Alix-Panabières C; Pierga JY
    Bull Cancer; 2014 Jan; 101(1):17-23. PubMed ID: 24445939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study.
    Horimoto Y; Tokuda E; Murakami F; Uomori T; Himuro T; Nakai K; Orihata G; Iijima K; Togo S; Shimizu H; Saito M
    J Transl Med; 2018 Oct; 16(1):287. PubMed ID: 30342534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescence virus-guided capturing system of human colorectal circulating tumour cells for non-invasive companion diagnostics.
    Shigeyasu K; Tazawa H; Hashimoto Y; Mori Y; Nishizaki M; Kishimoto H; Nagasaka T; Kuroda S; Urata Y; Goel A; Kagawa S; Fujiwara T
    Gut; 2015 Apr; 64(4):627-35. PubMed ID: 24870621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumour cells in metastatic head and neck cancers.
    Kulasinghe A; Perry C; Jovanovic L; Nelson C; Punyadeera C
    Int J Cancer; 2015 Jun; 136(11):2515-23. PubMed ID: 25111594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essentials of circulating tumor cells for clinical research and practice.
    Liberko M; Kolostova K; Bobek V
    Crit Rev Oncol Hematol; 2013 Nov; 88(2):338-56. PubMed ID: 23830807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-mesenchymal transition: a hallmark in metastasis formation linking circulating tumor cells and cancer stem cells.
    Książkiewicz M; Markiewicz A; Zaczek AJ
    Pathobiology; 2012; 79(4):195-208. PubMed ID: 22488297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumour cells and circulating free nucleic acid as prognostic and predictive biomarkers in colorectal cancer.
    Lim SH; Becker TM; Chua W; Caixeiro NJ; Ng WL; Kienzle N; Tognela A; Lumba S; Rasko JE; de Souza P; Spring KJ
    Cancer Lett; 2014 Apr; 346(1):24-33. PubMed ID: 24368189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapy.
    Chebouti I; Kasimir-Bauer S; Buderath P; Wimberger P; Hauch S; Kimmig R; Kuhlmann JD
    Oncotarget; 2017 Jul; 8(30):48820-48831. PubMed ID: 28415744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.